Cystic fibrosis (CF) is most commonly caused by deletion of a single amino acid (ΔF508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This mutation causes protein misfolding and disrupts many cellular functions. Many models of CFTRΔF508 misfolding exist, but none are amenable to rapid genetic dissection of the pathways that are disrupted by the mutation. He et al. now report a fluorescence-based C. elegans model that will enable such studies. They show that expressing the ΔF508 mutation in P-glycoprotein-3 (PGP-3), which is similar to mammalian CFTR, disrupts protein folding and prevents CFTR trafficking to the apical membrane of epithelial cells; this resembles the effects of the CFTRΔF508 mutation, and is rescued by the same treatments as in mammalian cells. This model will enable unbiased genetic screens for modulators of CFTR misfolding and hopefully uncover new therapeutic targets. Page 930
In vivo model for modulators of CFTRΔF508 misfolding
In vivo model for modulators of CFTRΔF508 misfolding. Dis Model Mech 1 November 2012; 5 (6): 707. doi:
Download citation file:
Advertisement
Cited by
Valuing peer review at Disease Models & Mechanisms
We would like to thank our peer reviewers who contributed their time and expertise in 2023. In her latest Editorial, Editor-in-Chief Liz Patton has outlined why we continue to value our peer reviewers dedication.
Subject collection: Building advocacy into research
DMM’s new series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Travelling Fellowships for early-career researchers
DMM and its sister journals offer Travelling Fellowships of up to £3,000 to graduate students and post-doctoral researchers wishing to make collaborative visits to other laboratories. Find out more about our Travelling Fellowships and read stories from previous grant recipients.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
The Forest of Biologists
Our Publisher Claire Moulton recently visited the two Woodland Trust UK sites where we are planting new native trees for published Research and Review papers and protecting ancient woodland on behalf of our peer reviewers.
Other journals from
The Company of Biologists